Colorado Healthcare Providers for Freedom is a non-profit network of physicians, healthcare providers that exists to support medical freedom and patient choice. We stand for patient rights, the doctor-patient relationship, individualized patient care, informed consent, and medical privacy. We are committed to serving our patients with integrity and compassion and will advocate for the best care available.
SERVICE
UNITY
INTEGRITY
HUMILITY
IMPACTFUL
Current resources-Nuerology
Spectrum of neurological complications following COVID-19 vaccination: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8557950/
COVID-19 mRNA vaccination leading to CNS inflammation: a case series https://link.springer.com/article/10.1007/s00415-021-10780-7?fbclid=IwAR1WIozzELtGyD_DttkLNZFMcl3yW6iBW9C0v8uRyiYtTulzRvKVPE_xYko
A systematic review of cases of CNS demyelination following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34839149/
Spectrum of neuroimaging findings in post-covid-19 vaccination: a case series and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34842783/
Neurologic autoimmune diseases following vaccinations: https://pubmed.ncbi.nlm.nih.gov/34668274/
New-onset autoimmune phenomena post COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34957554/
Neurologic side effects of COVID-19 vaccinations: https://pubmed.ncbi.nlm.nih.gov/34750810/
The potential neurological effect of the COVID‐19 vaccines: A review https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250748/
Rebuttal about Functional Neurologic Disorders and Vaccination: https://onlinelibrary.wiley.com/doi/full/10.1002/ana.26160?fbclid=IwAR3C-QQc-ZDEDoCu0fWNQuVYzvbC3qYHGekCaicU5-l_bOUz4N52jl1wjJ0
Neurologic safety monitoring of COVID-19 vaccines, lessons learned from the past to inform the present: https://pubmed.ncbi.nlm.nih.gov/34475124/
Neurological side effects after first dose AstraZeneca and COVID-19 infection: https://pubmed.ncbi.nlm.nih.gov/34697502/
Covid Vaccines are not free of Neurologic side effects: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206845/
Combined central and peripheral demyelination with Anti-neurofascin155 IgG following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35107062/
Intracranial aneurysm rupture within 3 days of receiving mRNA vaccination: 3 case reports: https://pubmed.ncbi.nlm.nih.gov/35509565/
Cerebrovascular complications of COVID-19 and COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/35420916/
Current resources- GBS
GBS (Guillain Barre Syndrome):
12 cases of GBS and 4 cases of CIDP following COVID-19 vaccination in the UK: https://pubmed.ncbi.nlm.nih.gov/34786740/
24 cases of GBS following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34967005/
Sensory GBS in a 16yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35097156/
Sensory ataxic GBS with immunoglobulin G anti-GM1 antibodies following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34871447/
AstraZeneca and GBS: analysis using National Immunoglobulin Database: https://pubmed.ncbi.nlm.nih.gov/35180300/
GBS following Johnson and Johnson: https://www.onlinescientificresearch.com/articles/the-development-of-guillain-barre-syndrome-subsequent-to-administration-of-ad26cov2s-vaccine.pdf
GBS following 2nd dose of Pfizer:, electromyoneurography and laboratory findings: https://pubmed.ncbi.nlm.nih.gov/34347563/
3 cases of GBS in Alberta following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/35747886/
GBS in a 23yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35528113/
Sensory ataxic GBS in a 80yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/35342134/
GBS in a 58yoF with rapid onset and autonomic dysfunction following 1st dose Pfizer: https://pubmed.ncbi.nlm.nih.gov/35401916/
GBS in a 80yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/35441015/
GBS in a 25yoF following 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34346014/
GBS following Pfizer in a 42yoM : https://pubmed.ncbi.nlm.nih.gov/34779385/
GBS in a 42yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34567447/
GBS in a 61yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34484780/
GBS in a 65yoM liver transplant patient following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34431208/
GBS in a 67yoM following 1st dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34796417/
GBS in a 73yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34477091/
GBS in 73yoM following 2nd dose of Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253659/
GBS in 82yoF following 1st dose Pfizer: https://pubmed.ncbi.nlm.nih.gov/33758714/
GBS 10 days after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34272622/
GBS 11 days after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34187803/
GBS following AstraZeneca with papilledema as atypical onset: https://pubmed.ncbi.nlm.nih.gov/34418708/
GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34330729/
GBS in a 63yo patient who had previous vaccine associated GBS syndrome following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34810163/
Recurrent GBS following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34468703/
3 cases of GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34548920/
3 cases of GBS and 1 case of CIDP following AstraZeneca in Tasmania: https://pubmed.ncbi.nlm.nih.gov/34560365/
7 cases of GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34114256/
19 cases of GBS following J&J, Pfizer, and Astra Zeneca vaccination: https://pubmed.ncbi.nlm.nih.gov/34644738/
GBS following vaccination, a review of 39 cases: https://pubmed.ncbi.nlm.nih.gov/34648420/
2 cases of Sensory GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416410/
Bilateral facial weakness with paresthesia variant of GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34261746/
Bifacial diplegia variant of GBS following J&J vaccination: https://pubmed.ncbi.nlm.nih.gov/34449715/
GBS presenting as bifacial diplegia in 2 patients following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34649856/
GBS following Johnson and Johnson: https://pubmed.ncbi.nlm.nih.gov/34550109/
GBS following Moderna: https://pubmed.ncbi.nlm.nih.gov/34767184/
GBS following 1st dose AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34217513/
GBS with Prominent Facial Diplegia after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34808658/
GBS in a 14yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34717201/
GBS in a 21yoM following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34981285/
GBS in a 38yoF following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34988954/
GBS in a 49yoF following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34703690/
2 cases of GBS following Pfizer in patients in remission from b-cell lymphoma: https://pubmed.ncbi.nlm.nih.gov/34929194/
2 cases of GBS after Pfizer and AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34593364/
GBS following COVID-10 vaccination: a report of 2 cases: https://pubmed.ncbi.nlm.nih.gov/34599482/
Facial Diplegia variant of GBS in a 38yoM following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34538679/
Facial Diplegia variant of GBS in a 65yoF following J&J: https://pubmed.ncbi.nlm.nih.gov/34447646/
Axonal-variant GBS in 86yoF temporally associated with Moderna vaccination: https://pubmed.ncbi.nlm.nih.gov/34722067/
Current resources-POTS
POTS (Postural Orthostatic Tachycardia Syndrome):
(See NIH Publication in neuropathy section above)
Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine: https://link.springer.com/article/10.1007/s10286-022-00880-3 https://pubmed.ncbi.nlm.nih.gov/35870086/
POTS following Pfizer: https://pubmed.ncbi.nlm.nih.gov/33968543/ https://www.cureus.com/articles/56242-a-case-of-postural-orthostatic-tachycardia-syndrome-secondary-to-the-messenger-rna-covid-19-vaccine
Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine https://academic.oup.com/ehjcr/article/5/12/ytab472/6444985
5 cases of POTS following vaccination, age 17 and up: https://pubmed.ncbi.nlm.nih.gov/35870086/
Connect with health freedom providers from all across the state
Protect our children!
Sign petition here